tradingkey.logo

Enhabit Inc

EHAB
11.130USD
+0.110+1.00%
Close 02/06, 16:00ETQuotes delayed by 15 min
563.18MMarket Cap
LossP/E TTM

Enhabit Inc

11.130
+0.110+1.00%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Enhabit Inc

Currency: USD Updated: 2026-02-06

Key Insights

Enhabit Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 11 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 11.75.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Enhabit Inc's Score

Industry at a Glance

Industry Ranking
11 / 75
Overall Ranking
69 / 4521
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Enhabit Inc Highlights

StrengthsRisks
Enhabit, Inc. is a provider of home health and hospice services in the United States. Its segments include Home Health and Hospice. The Home Health segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. It works closely with patients, families, caregivers, and physicians to deliver data-driven, evidence-based care plans focused on patient needs and goals. Its home health services are provided by nurses, physical, occupational and speech therapists, medical social workers, and home health aides. The Hospice segment provides hospice services to terminally ill patients and their families. Hospice care focuses on the quality of life for patients experiencing an advanced, life- limiting illness by treating the symptoms of the disease, rather than the disease itself. It operates about 115 hospice agencies and 255 home health agencies.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.03B.
Undervalued
The company’s latest PE is -45.42, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 52.65M shares, decreasing 0.04% quarter-over-quarter.
Held by Paul Tudor Jones
Star Investor Paul Tudor Jones holds 229.19K shares of this stock.

Analyst Rating

Based on 6 analysts
Buy
Current Rating
11.750
Target Price
+6.62%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Enhabit Inc is 7.90, ranking 39 out of 75 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 263.60M, representing a year-over-year increase of 3.94%, while its net profit experienced a year-over-year increase of 110.07%.

Score

Industry at a Glance

Previous score
7.90
Change
0

Financials

6.37

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

9.77

Operational Efficiency

8.82

Growth Potential

7.36

Shareholder Returns

7.19

Enhabit Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Enhabit Inc is 8.80, ranking 3 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -45.42, which is -95.29% below the recent high of -2.14 and -31.50% above the recent low of -59.72.

Score

Industry at a Glance

Previous score
8.80
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 11/75
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Enhabit Inc is 8.00, ranking 28 out of 75 in the Healthcare Providers & Services industry. The average price target is 9.25, with a high of 11.00 and a low of 8.50.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 6 analysts
Buy
Current Rating
11.750
Target Price
+6.62%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

67
Total
7
Median
9
Average
Company name
Ratings
Analysts
Enhabit Inc
EHAB
6
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
28
HCA Healthcare Inc
HCA
27
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
23
1
2
3
...
14

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Enhabit Inc is 8.61, ranking 23 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 11.67 and the support level at 10.27, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
8.51
Change
0.1

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(1)
Buy(3)
Indicators
Value
Direction
MACD(12,26,9)
0.007
Buy
RSI(14)
66.106
Neutral
STOCH(KDJ)(9,3,3)
76.318
Buy
ATR(14)
0.356
High Vlolatility
CCI(14)
111.068
Buy
Williams %R
19.298
Overbought
TRIX(12,20)
0.460
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
10.952
Buy
MA10
10.736
Buy
MA20
10.686
Buy
MA50
9.935
Buy
MA100
9.040
Buy
MA200
8.751
Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Enhabit Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 122.69%, representing a quarter-over-quarter decrease of 1.36%. The largest institutional shareholder is The Vanguard, holding a total of 3.30M shares, representing 6.52% of shares outstanding, with 11.57% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Deerfield Management Company, L.P.
4.75M
-0.67%
8 knots Management LLC
4.22M
+9.49%
BlackRock Institutional Trust Company, N.A.
3.43M
+2.53%
The Vanguard Group, Inc.
Star Investors
3.32M
+6.56%
AREX Capital Management, LP
2.49M
+0.26%
JANA Partners LLC
Star Investors
2.14M
--
Dimensional Fund Advisors, L.P.
1.98M
-2.93%
UBS Financial Services, Inc.
3.13M
-6.30%
Systematic Financial Management, L.P.
1.94M
-0.17%
LOYS AG
2.00M
-15.01%
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Enhabit Inc is 6.10, ranking 32 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 1.25. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
6.10
Change
0
Beta vs S&P 500 index
1.25
VaR
--
240-Day Maximum Drawdown
+39.63%
240-Day Volatility
+46.38%

Return

Best Daily Return
60 days
+8.39%
120 days
+8.39%
5 years
--
Worst Daily Return
60 days
-3.40%
120 days
-6.09%
5 years
--
Sharpe Ratio
60 days
+4.22
120 days
+2.33
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+39.63%
3 years
+54.82%
5 years
--
Return-to-Drawdown Ratio
240 days
+0.96
3 years
-0.12
5 years
--
Skewness
240 days
+0.59
3 years
-0.11
5 years
--

Volatility

Realised Volatility
240 days
+46.38%
5 years
--
Standardised True Range
240 days
+2.95%
5 years
--
Downside Risk-Adjusted Return
120 days
+440.19%
240 days
+440.19%
Maximum Daily Upside Volatility
60 days
+37.99%
Maximum Daily Downside Volatility
60 days
+27.61%

Liquidity

Average Turnover Rate
60 days
+1.27%
120 days
+1.00%
5 years
--
Turnover Deviation
20 days
-0.53%
60 days
+19.29%
120 days
-5.96%

Peer Comparison

Healthcare Providers & Services
Enhabit Inc
Enhabit Inc
EHAB
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ensign Group Inc
Ensign Group Inc
ENSG
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Encompass Health Corp
Encompass Health Corp
EHC
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Quest Diagnostics Inc
Quest Diagnostics Inc
DGX
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cigna Group
Cigna Group
CI
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Labcorp Holdings Inc
Labcorp Holdings Inc
LH
8.44 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI